Balance Sheet Mycronic AB

Stocks

MYCR

SE0025158629

Semiconductor Equipment & Testing

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2026-07-14 pm EDT			5-day change	1st Jan Change
339.20 ^SEK	+15.30%		+13.75%	+51.94%

Jul. 14	Mycronic AB Revises Revenue Guidance for Year 2026	CI
Jul. 14	Ericsson slid on the Stockholm exchange, the OMXS30 index fell 0.1 percent	FW

77051906128530ecb6.MdDDUGoHWCDkLPBZd6Twb_83YTiAGlWwr-uw51l2oKc.ZbKIFwRVHG69Wr4IA86aPLtdDX3ldQz_7aaDtwYAzvNh4_UPNWIMTbMbvQ

Published financial data: MYCRONIC AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	4.64B	5.12B	5.71B	7.06B	7.94B
Total Revenues	4.64B	5.12B	5.71B	7.06B	7.94B
Cost of Goods Sold, Total	2.32B	2.83B	2.85B	3.34B	3.74B
Gross Profit	2.31B	2.29B	2.86B	3.72B	4.2B
Selling General & Admin Expenses, Total	769M	889M	996M	989M	1.17B
R&D Expenses	548M	638M	653M	747M	978M
Other Operating Expenses	-55M	-98M	-44M	-31M	-37M
Other Operating Expenses, Total	1.26B	1.43B	1.6B	1.7B	2.11B
Operating Income	1.05B	859M	1.25B	2.02B	2.09B
Interest Expense, Total	-14M	-13M	-13M	-15M	-17M
Interest And Investment Income	11M	9M	40M	78M	46M
Net Interest Expenses	-3M	-4M	27M	63M	29M
Currency Exchange Gains (Loss)	27M	12M	-16M	6M	-77M
Other Non Operating Income (Expenses)	-	1M	-	1M	1M
EBT, Excl. Unusual Items	1.08B	868M	1.26B	2.09B	2.04B
Merger & Related Restructuring Charges	-30M	-	-	-2M	-71M
Gain (Loss) On Sale Of Assets	-	23M	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	1.05B	891M	1.26B	2.08B	1.97B
Income Tax Expense	219M	154M	266M	396M	410M
Earnings From Continuing Operations	827M	737M	996M	1.69B	1.56B
Net Income to Company	827M	737M	996M	1.69B	1.56B
Minority Interest	1M	4M	2M	-5M	-
Net Income - (IS)	828M	741M	998M	1.68B	1.56B
Net Income to Common Incl Extra Items	828M	741M	998M	1.68B	1.56B
Net Income to Common Excl. Extra Items	828M	741M	998M	1.68B	1.56B
Per Share Items
Net EPS - Basic	4.24	3.8	5.11	8.62	7.99
Basic EPS - Continuing Operations	4.24	3.8	5.11	8.62	7.99
Basic Weighted Average Shares Outstanding	195M	195M	195M	195M	195M
Net EPS - Diluted	4.24	3.8	5.11	8.62	7.99
Diluted EPS - Continuing Operations	4.24	3.8	5.11	8.62	7.99
Diluted Weighted Average Shares Outstanding	195M	195M	195M	195M	195M
Normalized Basic EPS	3.45	2.8	4.05	6.65	6.53
Normalized Diluted EPS	3.45	2.8	4.05	6.65	6.53
Dividend Per Share	1.5	1.75	2.25	2.75	3.25
Payout Ratio	35.51	39.68	34.37	26.2	47.05
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.13B	994M	1.39B	2.14B	2.26B
EBITA	1.07B	932M	1.31B	2.07B	2.17B
EBIT	1.05B	859M	1.25B	2.02B	2.09B
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	20.94	17.28	21.08	19	20.81
Total Current Taxes	188M	196M	251M	364M	420M
Total Deferred Taxes	31M	-42M	15M	33M	-9M
Normalized Net Income	674M	546M	791M	1.3B	1.28B
Interest on Long-Term Debt	5M	5M	6M	6M	7M
Non-Cash Pension Expense	100K	-200K	-1.3M	-200K	0
Supplemental Operating Expense Items
Selling and Marketing Expenses	526M	611M	658M	628M	717M
General and Administrative Expenses	243M	278M	338M	361M	456M
Research And Development Expense From Footnotes	548M	638M	653M	747M	978M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	3.3M	5.6M	43M
Total Stock-Based Compensation	-	-	3.3M	5.6M	43M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	683M	1.27B	2.14B	3.01B	2.32B
Total Cash And Short Term Investments	683M	1.27B	2.14B	3.01B	2.32B
Accounts Receivable, Total	776M	1.2B	1.3B	1.58B	1.5B
Other Receivables	157M	230M	220M	158M	380M
Total Receivables	933M	1.43B	1.52B	1.74B	1.88B
Inventory	1.36B	1.43B	1.6B	2.06B	2.15B
Prepaid Expenses	45M	61M	55M	73M	94M
Other Current Assets, Total	186M	-	-1M	-	-
Total Current Assets	3.21B	4.2B	5.32B	6.88B	6.45B
Gross Property Plant And Equipment	914M	1.08B	1.18B	1.37B	1.55B
Accumulated Depreciation	-485M	-563M	-680M	-796M	-854M
Net Property Plant And Equipment	429M	513M	495M	574M	699M
Goodwill	1.74B	1.87B	1.8B	2.1B	2.65B
Other Intangibles, Total	430M	390M	351M	405M	693M
Accounts Receivable Long-Term	6M	13M	9M	4M	6M
Deferred Tax Assets Long-Term	145M	193M	175M	214M	193M
Deferred Charges Long-Term	127M	118M	140M	177M	185M
Other Long-Term Assets, Total	50M	52M	50M	55M	51M
Total Assets	6.14B	7.34B	8.34B	10.41B	10.92B
Liabilities
Accounts Payable, Total	295M	310M	388M	557M	465M
Accrued Expenses, Total	479M	554M	547M	612M	634M
Short-term Borrowings	-	-	-	4M	-
Current Portion of Long-Term Debt	8M	-	-	-	-
Current Portion of Leases	54M	77M	78M	83M	96M
Current Income Taxes Payable	24M	50M	88M	264M	172M
Unearned Revenue Current, Total	481M	830M	1.21B	1.4B	1.19B
Other Current Liabilities	228M	241M	196M	288M	239M
Total Current Liabilities	1.57B	2.06B	2.51B	3.2B	2.8B
Long-Term Debt	-	7M	-	-	12M
Long-Term Leases	181M	186M	150M	133M	240M
Pension & Other Post Retirement Benefits	41M	36M	33M	32M	28M
Deferred Tax Liability Non Current	329M	335M	359M	405M	526M
Other Non Current Liabilities	19M	11M	8M	62M	209M
Total Liabilities	2.14B	2.64B	3.06B	3.84B	3.81B
Common Stock, Total	98M	98M	98M	98M	98M
Additional Paid In Capital	1.35B	1.36B	1.37B	1.39B	1.41B
Retained Earnings	2.42B	2.85B	3.49B	4.71B	5.57B
Comprehensive Income and Other	91M	354M	290M	333M	26M
Total Common Equity	3.96B	4.66B	5.25B	6.53B	7.11B
Minority Interest	42M	40M	36M	43M	-
Total Equity	4B	4.7B	5.28B	6.58B	7.11B
Total Liabilities And Equity	6.14B	7.34B	8.34B	10.41B	10.92B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	196M	195M	195M	196M	195M
ECS Total Common Shares Outstanding	196M	195M	195M	196M	195M
Book Value / Share	20.2	23.88	26.88	33.35	36.41
Tangible Book Value	1.79B	2.41B	3.1B	4.02B	3.77B
Tangible Book Value Per Share	9.12	12.33	15.86	20.54	19.31
Total Debt	243M	270M	228M	220M	348M
Net Debt	-440M	-1B	-1.91B	-2.79B	-1.98B
Debt Equivalent of Unfunded Proj. Benefit Obligation	41.2M	34M	30.5M	30.8M	24.6M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	42M	40M	36M	43M	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	404M	531M	594M	732M	785M
Inventories - Work In Process, Total	253M	236M	340M	514M	525M
Inventories - Finished Goods, Total	706M	666M	668M	810M	840M
Buildings, Total	-	4M	4M	5M	93M
Machinery, Total	475M	546M	599M	651M	712M
Full Time Employees	1.77K	1.99K	1.98K	2.16K	2.49K
Part Time Employees	-	63	66	76	101
Accumulated Allowance for Doubtful Accounts (Supple)	26M	47M	51M	46M	59M
Order Backlog	1.98B	3.57B	4.15B	4.7B	4.68B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	828M	741M	998M	1.68B	1.56B
Depreciation & Amortization - CF	116M	134M	155M	156M	180M
Amortization of Goodwill and Intangible Assets - (CF)	21M	73M	63M	56M	85M
Depreciation & Amortization, Total	137M	207M	218M	212M	265M
Amortization of Deferred Charges, Total - (CF)	68M	46M	46M	54M	65M
(Gain) Loss From Sale Of Asset	2M	-23M	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	-	-	-	-	43M
Other Operating Activities, Total	31M	-5M	208M	249M	23M
Change In Accounts Receivable	110M	-414M	-210M	-145M	41M
Change In Inventories	-26M	-26M	-235M	-433M	-231M
Change In Accounts Payable	-1M	-2M	94M	147M	-62M
Change in Other Net Operating Assets	-151M	329M	489M	107M	-297M
Cash from Operations	998M	853M	1.61B	1.87B	1.41B
Capital Expenditure	-42M	-107M	-103M	-126M	-91M
Sale of Property, Plant, and Equipment	-	-	1M	-	1M
Cash Acquisitions	-1.12B	-	-6M	-258M	-952M
Divestitures	-	216M	-	-	-
Sale (Purchase) of Intangible assets	-48M	-34M	-89M	-112M	-74M
Other Investing Activities, Total	-16M	-8M	2M	-4M	-13M
Cash from Investing	-1.22B	67M	-195M	-500M	-1.13B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	7M	-	3M	-
Total Debt Issued	-	7M	-	3M	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-83M	-84M	-88M	-95M	-109M
Total Debt Repaid	-83M	-84M	-88M	-95M	-109M
Repurchase of Common Stock	-23M	-16M	-26M	-19M	-19M
Common Dividends Paid	-294M	-294M	-343M	-441M	-734M
Common & Preferred Stock Dividends Paid	-294M	-294M	-343M	-441M	-734M
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-37M	5M	10M	-	-
Cash from Financing	-437M	-382M	-447M	-552M	-862M
Foreign Exchange Rate Adjustments	51M	44M	-100M	53M	-107M
Miscellaneous Cash Flow Adjustments	-9M	-	-	-1M	-
Net Change in Cash	-620M	582M	866M	874M	-691M
Supplemental Items
Cash Interest Paid	14M	13M	13M	15M	16M
Cash Income Tax Paid (Refund)	181M	141M	188M	201M	495M
Levered Free Cash Flow	520M	725M	1.04B	1.29B	825M
Unlevered Free Cash Flow	528M	733M	1.04B	1.3B	836M
Change In Net Working Capital	244M	-84M	-186M	-3M	677M
Net Debt Issued / Repaid	-83M	-77M	-88M	-92M	-109M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	11.48	7.97	9.97	13.44	12.23
Return on Total Capital	16.68	11.65	14.92	20.48	18.31
Return On Equity %	22.43	16.94	19.95	28.47	22.8
Return on Common Equity	22.63	17.2	20.14	28.58	22.87
Margin Analysis
Gross Profit Margin %	49.92	44.7	50.05	52.73	52.94
SG&A Margin	16.59	17.37	17.46	14.01	14.78
EBITDA Margin %	24.31	19.42	24.33	30.4	28.47
EBITA Margin %	23.15	18.21	23.03	29.36	27.37
EBIT Margin %	22.7	16.78	21.92	28.57	26.3
Income From Continuing Operations Margin %	17.84	14.4	17.46	23.92	19.65
Net Income Margin %	17.86	14.48	17.49	23.85	19.65
Net Avail. For Common Margin %	17.86	14.48	17.49	23.85	19.65
Normalized Net Income Margin	14.53	10.68	13.86	18.4	16.07
Levered Free Cash Flow Margin	11.21	14.16	18.14	18.24	10.4
Unlevered Free Cash Flow Margin	11.4	14.32	18.28	18.37	10.53
Asset Turnover
Asset Turnover	0.81	0.76	0.73	0.75	0.74
Fixed Assets Turnover	10.36	10.87	11.32	13.2	12.47
Receivables Turnover (Average Receivables)	6.39	5.19	4.56	4.9	5.15
Inventory Turnover (Average Inventory)	1.82	2.03	1.88	1.82	1.78
Short Term Liquidity
Current Ratio	2.05	2.03	2.12	2.15	2.3
Quick Ratio	1.03	1.31	1.46	1.48	1.5
Operating Cash Flow to Current Liabilities	0.64	0.41	0.64	0.58	0.5
Days Sales Outstanding (Average Receivables)	57.13	70.34	79.96	74.74	70.81
Days Outstanding Inventory (Average Inventory)	200.03	180.24	194.35	200.66	205.46
Average Days Payable Outstanding	40.54	38.06	42.19	45.63	48.7
Cash Conversion Cycle (Average Days)	216.63	212.52	232.11	229.77	227.57
Long Term Solvency
Total Debt/Equity	6.08	5.74	4.32	3.35	4.9
Total Debt / Total Capital	5.73	5.43	4.14	3.24	4.67
LT Debt/Equity	4.53	4.1	2.84	2.02	3.54
Long-Term Debt / Total Capital	4.27	3.88	2.72	1.96	3.38
Total Liabilities / Total Assets	34.86	35.93	36.65	36.85	34.91
EBIT / Interest Expense	75.14	66.08	96.23	134.4	122.82
EBITDA / Interest Expense	84.93	82	113	148.53	138.41
(EBITDA - Capex) / Interest Expense	81.93	73.77	105.08	140.13	133.06
Total Debt / EBITDA	0.2	0.25	0.16	0.1	0.15
Net Debt / EBITDA	-0.37	-0.94	-1.3	-1.25	-0.84
Total Debt / (EBITDA - Capex)	0.21	0.28	0.17	0.1	0.15
Net Debt / (EBITDA - Capex)	-0.38	-1.05	-1.4	-1.33	-0.87
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	19.4	10.44	11.47	23.68	12.48
Gross Profit, 1 Yr. Growth %	11.25	-1.12	24.83	30.29	12.93
EBITDA, 1 Yr. Growth %	8.68	-13.72	39.64	54.54	5.36
EBITA, 1 Yr. Growth %	7.84	-15.12	40.99	57.69	4.87
EBIT, 1 Yr. Growth %	10.74	-18.35	45.63	61.15	3.57
Earnings From Cont. Operations, 1 Yr. Growth %	17.47	-10.88	35.14	69.48	-7.58
Net Income, 1 Yr. Growth %	19.31	-10.51	34.68	68.64	-7.31
Normalized Net Income, 1 Yr. Growth %	20.67	-18.86	44.69	64.24	-1.78
Diluted EPS Before Extra, 1 Yr. Growth %	19.43	-10.49	34.65	68.69	-7.31
Accounts Receivable, 1 Yr. Growth %	14.96	54.25	8.86	21.01	-4.82
Inventory, 1 Yr. Growth %	15.41	5.14	11.79	28.34	4.57
Net Property, Plant and Equip., 1 Yr. Growth %	-7.94	19.58	-3.51	15.96	21.78
Total Assets, 1 Yr. Growth %	15.36	19.62	13.62	24.84	4.9
Tangible Book Value, 1 Yr. Growth %	-19.77	34.77	28.58	29.98	-6.27
Common Equity, 1 Yr. Growth %	17.57	17.9	12.52	24.49	8.83
Cash From Operations, 1 Yr. Growth %	-11.37	-14.53	88.51	16.54	-24.92
Capital Expenditures, 1 Yr. Growth %	-4.55	154.76	-3.74	22.33	-27.78
Levered Free Cash Flow, 1 Yr. Growth %	-38.85	39.44	42.81	24.76	-36.59
Unlevered Free Cash Flow, 1 Yr. Growth %	-38.46	38.67	42.34	24.69	-36.23
Dividend Per Share, 1 Yr. Growth %	0	16.67	28.57	22.22	18.18
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.74	14.83	10.95	17.41	17.95
Gross Profit, 2 Yr. CAGR %	-1.79	4.88	11.1	27.53	21.3
EBITDA, 2 Yr. CAGR %	-4.16	-2.1	9.77	46.9	27.6
EBITA, 2 Yr. CAGR %	-5.16	-3.22	9.39	49.1	28.6
EBIT, 2 Yr. CAGR %	-3.6	-4.91	9.05	53.2	29.19
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.88	2.32	9.74	51.34	25.15
Net Income, 2 Yr. CAGR %	-1.59	3.33	9.79	50.71	25.02
Normalized Net Income, 2 Yr. CAGR %	-1.72	-1.05	8.36	54.16	27.01
Diluted EPS Before Extra, 2 Yr. CAGR %	-1.47	3.39	9.79	50.71	25.04
Accounts Receivable, 2 Yr. CAGR %	-6.62	33.17	29.58	14.82	7.32
Inventory, 2 Yr. CAGR %	10.86	10.15	8.41	19.78	15.85
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.03	4.92	7.42	5.78	18.83
Total Assets, 2 Yr. CAGR %	13.06	17.47	16.58	19.1	14.44
Tangible Book Value, 2 Yr. CAGR %	3.85	3.99	31.64	29.28	10.37
Common Equity, 2 Yr. CAGR %	15.36	17.73	15.18	18.36	16.4
Cash From Operations, 2 Yr. CAGR %	35.32	-12.96	26.93	48.22	-6.46
Capital Expenditures, 2 Yr. CAGR %	-37.93	55.94	56.6	8.52	-6.01
Levered Free Cash Flow, 2 Yr. CAGR %	548.07	-7.66	41.12	33.27	-10.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	880.26	-7.62	40.49	33.01	-10.34
Dividend Per Share, 2 Yr. CAGR %	22.47	8.01	22.47	25.36	20.18
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.02	5.93	13.7	15.04	15.75
Gross Profit, 3 Yr. CAGR %	3.32	-1.57	11.15	17.16	22.46
EBITDA, 3 Yr. CAGR %	2	-6.78	10.21	23.02	31.49
EBITA, 3 Yr. CAGR %	1.14	-7.9	9.71	23.57	32.6
EBIT, 3 Yr. CAGR %	1.84	-8.79	9.61	24.21	34.46
Earnings From Cont. Operations, 3 Yr. CAGR %	1.41	-4.98	12.26	26.85	28.4
Net Income, 3 Yr. CAGR %	1.58	-4.66	12.87	26.67	28.16
Normalized Net Income, 3 Yr. CAGR %	2.65	-7.8	12.31	24.47	32.65
Diluted EPS Before Extra, 3 Yr. CAGR %	1.67	-4.57	12.91	26.68	28.17
Accounts Receivable, 3 Yr. CAGR %	0.39	10.38	24.51	26.69	7.86
Inventory, 3 Yr. CAGR %	16.23	8.92	10.7	14.69	14.48
Net Property, Plant and Equip., 3 Yr. CAGR %	59.36	4.7	2.03	10.19	10.86
Total Assets, 3 Yr. CAGR %	13.48	15.21	16.17	19.28	14.17
Tangible Book Value, 3 Yr. CAGR %	20.26	13.28	11.61	31.09	16.13
Common Equity, 3 Yr. CAGR %	18.51	16.2	15.97	18.2	15.09
Cash From Operations, 3 Yr. CAGR %	12.44	16.1	12.61	23.37	18.15
Capital Expenditures, 3 Yr. CAGR %	-8.04	-0.62	32.78	44.22	-5.26
Levered Free Cash Flow, 3 Yr. CAGR %	-3.42	288.34	6.79	35.3	4.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	-3.29	410.77	6.7	34.87	4.49
Dividend Per Share, 3 Yr. CAGR %	0	20.51	14.47	22.39	22.92
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.85	11.28	8.58	10.38	15.38
Gross Profit, 5 Yr. CAGR %	10.41	5.92	6.36	9.18	15.1
EBITDA, 5 Yr. CAGR %	9.49	1.06	5.5	11.82	16.86
EBITA, 5 Yr. CAGR %	8.82	0.15	4.85	11.67	16.91
EBIT, 5 Yr. CAGR %	8.61	-0.79	4.66	12.24	17.06
Earnings From Cont. Operations, 5 Yr. CAGR %	9.46	3.41	4.66	14.47	17.25
Net Income, 5 Yr. CAGR %	9.49	3.5	4.79	14.5	17.59
Normalized Net Income, 5 Yr. CAGR %	9.18	0.14	4.9	13.25	17.98
Diluted EPS Before Extra, 5 Yr. CAGR %	9.55	3.57	4.84	14.57	17.62
Accounts Receivable, 5 Yr. CAGR %	2.66	16.68	11.18	12.14	17.35
Inventory, 5 Yr. CAGR %	18.85	19.48	13.04	13.14	12.73
Net Property, Plant and Equip., 5 Yr. CAGR %	48.17	49.14	36.1	5.13	8.45
Total Assets, 5 Yr. CAGR %	17.37	17.74	14.71	16.75	15.48
Tangible Book Value, 5 Yr. CAGR %	37.82	25.51	24.69	19.43	11.11
Common Equity, 5 Yr. CAGR %	22.88	21.24	17.17	17.06	16.14
Cash From Operations, 5 Yr. CAGR %	16.66	-2.81	18.03	28.02	4.56
Capital Expenditures, 5 Yr. CAGR %	3.67	30.49	13.79	2.94	15.64
Levered Free Cash Flow, 5 Yr. CAGR %	14.47	0.01	12.4	153.18	-0.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.75	0.07	12.29	198.19	-0.54
Dividend Per Share, 5 Yr. CAGR %	8.45	6.96	8.45	22.42	16.72